Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hefei Zhongke Presheng Biomedical Technology

Request full access

Specialized cell engineering services for targeted drug development

ChinaFounded 2015

About Hefei Zhongke Presheng Biomedical Technology

Hefei Zhongke Presheng Biomedical Technology Co., Ltd. is a high-tech enterprise established in 2015, with backing from state-owned industrial capital and research support from the Hefei Institutes of Physical Science, Chinese Academy of Sciences. The company was co-founded by Liu Qingsong, Liu Jing, Wang Wenchao, and Ren Tao, four of the scientists known as the 'Harvard Eight'. It focuses on core cell engineering technologies to address bottlenecks in the biopharmaceutical field, particularly in oncology.

The company provides technical support services for drug research and development institutions and offers precision medicine consulting for medical establishments. Its business model centers on creating and utilizing extensive cell banks to support preclinical drug screening, efficacy evaluation, and personalized cancer treatment. Key assets include the Ba/F3 cancer kinase target engineering cell bank, which is among the world's largest, and the China Living Primary Cancer Cell Bank (LPCB). These resources are used for high-throughput drug sensitivity screening and to develop patient-derived xenograft (PDX), patient-derived organoid (PDO), and patient-derived cell (PDC) models. This infrastructure supports the development of novel targeted drugs and provides critical data for clinical precision medicine.

Zhongke Presheng serves the broader health industry by providing the foundational resources for the entire biopharmaceutical development chain. It has established collaborations with major hospitals in Anhui province, delivering personalized medication plans for hundreds of cancer patients based on its proprietary drug sensitivity testing technology. The company's mission is to advance precision oncology and make it more accessible, contributing to the 'Healthy China' national strategy.

Source: Dealroom company data

At a glance

Status
Operational
Employees
5
Open positions
None listed
Dealroom signal
27.3/100

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Nov 2023 $14M $55M Sunland fund ↗
SERIES B✓Equity / VC May 2022 $0 — Hefei Industry Investment Group —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Hefei Zhongke Presheng Biomedical Technology website traffic

Latest recorded traffic for Hefei Zhongke Presheng Biomedical Technology is 920 monthly website visits, up 2966.7% over the last three months. Hefei Zhongke Presheng Biomedical Technology's team declined 16.7% over the past year.

Latest monthly visits920 3-month web change+2966.7% 1-year team growth-16.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Hefei Zhongke Presheng Biomedical Technology in its local ecosystem

Live from Dealroom

The Hefei Zhongke Presheng Biomedical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Anhui High-tech Venture Capital

Series A1 investor entered at this stage

  • Hefei Industry Investment Group

Series B and later1 investor entered at this stage

  • Sunland fund
Employees 5 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hefei Zhongke Presheng Biomedical Technology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hefei Zhongke Presheng Biomedical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.